chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Only initial reaction noted from vaccine was sore arm and some fatigue. On Oct 1st noted my left elbow and left knee sore with movement. (No precipitating event to cause this.) On Nov 3 woke up in middle of night with extremely painful stiff neck, swollen left knee warm to touch. Left elbow continued sore. Nov 4 difficult to walk, neck pain continued so went to Hospital ER. Seen by PA who did an xray of knee and work up for gout, tick borne diseases (both negative). PA and I (a retired RN) felt this was likely a reaction to the vaccine I had had 10 days prior to symptoms. Discharged from ER with Medrol Dospak and diclofenac topical. Nov 6 right knee now swollen but left improving. Nov 12 OK.
Breakthrough COVID infection. Patient fully vaccinated on June 2, 2021. Patient tested positive for COVID on Nov 15, 2021.
Severe swelling of lymph nodes in left armpit area with significant associated pain; Severe swelling of lymph nodes in left armpit area with significant associated pain; itchy rash around the injection site; itchy rash around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medication was not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200), via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. The patient was not allergic to any medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 the patient experienced severe swelling of lymph nodes in the left armpit area with significant associated pain. The patient reported that swelling started less than 24 hours after the 2nd vaccine, and it was been over 48 hours since the injection and the swelling and pain level had continued to increase. Additionally, on the same day, the patient had experienced an itchy rash around the injection site that was also increasing in size quickly. The patient reported that she did not experience any of these side effects after her first injection. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe swelling of lymph nodes in the left armpit area with significant associated pain and itchy rash around the vaccination site were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Left arm swollen, blotchy red warm from lower shoulder to elbow. DTaP and MMR given at left deltoid on 04/01/2003. Pt in on 04/04/2003 to check PPD results-RN observed left arm and made for MD to examine arm.
experiencing a severe migraine headache; Vomiting; body aches; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (experiencing a severe migraine headache), VOMITING (Vomiting) and MYALGIA (body aches) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced MIGRAINE (experiencing a severe migraine headache), VOMITING (Vomiting) and MYALGIA (body aches). At the time of the report, MIGRAINE (experiencing a severe migraine headache), VOMITING (Vomiting) and MYALGIA (body aches) outcome was unknown.            Concomitant medications was not reported.  Treatment medications was not reported.
Enlarge lymph node under Right arm/ same arm as shot felt like bruising for 2 days, continues to be swollen but less. U/S x 2, 2 blood tests, 4 doctor appointment, including surgeon.
Information has been received from a Certified Medical Assistant referring to a 16 year old male patient. On 01-APR-2015 the patient was vaccinated with (Merck) PROQUAD (lot # K020755, expiration date 30-APR-2016, dose not reported) subcutaneously (Inappropriate schedule of drug administration). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Inconsolable crying all night. Not sleeping. Next day, runny nose, fever off and on, fussing.
2 hours after the 2nd dose of the vaccine patient stated that they developed a cough and felt as if their throat was closing, they did not seek medical attention. 24 hours later patient still had a linger cough.
Extensive red rash macular rash on abdomen, face, chest, legs, back, fever, diarrhea, rash on arms. Went to her PCP Dr - no treatment ordered.
So within the 15 minute waiting period, I have nausea vomiting and chest tightness. When I went home, everything resolved except the tightness in my chest. I am now on an inhaler every 4 hours as needed. It has been that way since March. March 8, 2021 I saw the DR and got that inhaler.
Arm pain at injection site starting 5 hours post injection and continuing is intensity over the course of 12 hours.  Pain decreased and was not present after 24 hours.
Dizziness; does not feel well; tired; nausea; muscle pain; drain; muscle weakness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (drain), MUSCULAR WEAKNESS (muscle weakness), DIZZINESS (Dizziness), MALAISE (does not feel well) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol. Concomitant products included EVOLOCUMAB (REPATHA) for an unknown indication.   On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PYREXIA (Fever). On 16-Apr-2021, the patient experienced ASTHENIA (drain), MUSCULAR WEAKNESS (muscle weakness), MYALGIA (muscle pain) and NAUSEA (nausea). On an unknown date, the patient experienced DIZZINESS (Dizziness), MALAISE (does not feel well) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) on 08-Apr-2021 for Fever, at an unspecified dose and frequency. At the time of the report, ASTHENIA (drain), MUSCULAR WEAKNESS (muscle weakness), DIZZINESS (Dizziness), MALAISE (does not feel well), PYREXIA (Fever), MYALGIA (muscle pain), FATIGUE (tired) and NAUSEA (nausea) had resolved.            No concomitant medications were reported.  No treatment information was reported.    Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received contain outcome of the events such as Asthenia, Muscular weakness, Dizziness, Malaise, Pyrexia, Myalgia, Fatigue, Nausea to recovered/ resolved.
Patient immediately felt some pain in the muscles of the shoulder.  It became a constant dull ache which throbs with use.  Unfortunately, he works in a job that requires a lot of physical use.  He believes this is getting worse instead of better.
temperature of 99.8; lower back pain; severe headache; This is a spontaneous report from a contactable consumer (patient's husband). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: unknown) (Age at Time of Vaccination was 45 years) via unspecified route of administration on 24Jan2021 around 9-9:15 a.m. in the left arm as a single dose for COVID-19 immunization. There were no additional vaccines administered on same date of the Pfizer Suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history and Concomitant medication was not reported. It was reported that on Sunday, the caller and his wife received the vaccine. He does not have any symptoms. However, his wife had a severe headache and feels like the veins in her head are getting inflamed. Caller wants to know was this kind of a normal side effect or does she need to go to the hospital. Caller stated that his wife also had a temperature of 9.8 degrees (later clarified as 99.8 degrees). Caller tried to call the doctor, but no one answered. Caller confirmed that his wife received her first vaccine Sunday, 24Jan2021. That same night, she had a headache. She took pills for the headache and the headache went away. Monday, 25Jan2021, she had a light headache. Yesterday afternoon (26Jan2021), she had a really bad headache. The pain was getting bigger, she felt more pain in her head. It was confirmed that his wife's temperature was checked yesterday morning and it was 99.8 degrees. Today, she just took it and her temperature has gone up to 100 degrees. It was stated that his wife was also noticing some pain in her lower back. This pain started on Monday and it was not as strong as the pain in her head, but she was starting to feel more discomfort. The patient did not visit emergency Room/Physician Office. The outcome of the events was not recovered/not resolved.  Information about lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
24 hours after initial booster I experienced two symptoms. A heightened tinnitus (constant slow ringing in the ear) and left underarm lymph node above breast swollen and painful. The tinnitus has not gone away however the lymph node after 4 days went away.
Patient had  "blue" blisters in her mouth and a cold sore  the size of a penny on her lip She had pain every time she ate or drank with inside the mouth. She was putting campho phenique on the lip which may have further irritated but 6 days later she is much better besides cold sore on lip. She had  tomato color red  all the way to her elbow
Mom stated that approximately 1 hour after the 1st vaccine the patient had a bloody nose. She states she has never had a bloody nose before. The nose bleed was not severe and did not last long, she went and cleaned it up in the restroom and it had stopped bleeding.
Chills; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Apr-2021 and was forwarded to Moderna on 30-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (Headache) in a 35-year-old female patient who received mRNA-1273 (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). At the time of the report, CHILLS (Chills) and HEADACHE (Headache) had not resolved.            The patient reported that the chills were mild and headache has gotten worse.  No concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
within a week my upper left arm formed a softball size knot, red, inflammed and itching under the skin. continued to spread down my left arm to elbow, contacted my PCP and she prescribed me steriods and antibiotics, still have symptoms, not as bad, swelling will go away and come back, itching has began to calm down, site still red and forming a pattern in circular motion
A patient received a dose from a vial that was transported outside of the recommended policy.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (A patient received a dose from a vial that was transported outside of the recommended policy.) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (A patient received a dose from a vial that was transported outside of the recommended policy.). On 29-Jan-2022, PRODUCT STORAGE ERROR (A patient received a dose from a vial that was transported outside of the recommended policy.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The vial was removed from  the cooler (unpunctured), placed in a glove with two ice cubes and transported for 15 minutes to a different location. Upon new site, vaccine was then punctured and dose was administered.  No concomitant medications were reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2022: Follow-up received contains no new information.
This spontaneous report was received from a physician via a company representative and refers to an 81 year old female patient. The patient's concurrent conditions, medical history and allergies were not reported. In approximately 2012 (reported as about 3 or 4 years ago), the patient was vaccinated with a dose of ZOSTAVAX (dose, frequency, route, anatomical location, batch/lot number and expiration date were not reported). Other suspect and concomitant therapies were not reported. On an unspecified date in February 2016 (reported as "sometime this week"), the patient experienced rash on her forward trunk that appeared to be shingles. The patient sought medical attention from the reporting physician, on an unspecified date in February 2016, and she was treated with acyclovir. It was unspecified if laboratory diagnostic studies were performed. No product quality complaint (PQC) was involved. The outcome of rash on her forward trunk that appeared to be shingles was reported as recovering. The relatedness between the events and therapy with ZOSTAVAX was not reported. Additional information has been requested.
pt recv vax 1995 & 6APR96 pt devel a chickenpox rash on the buttocks w/about 15 lesions;as of 9APR96 some of the lesions had crusted over;no further details were provided;
After administering vaccine, realized that the dose was not diluted with diluent. So far mom has not reported to us any adverse event we have tried to follow-up and reach out to her Saturday, Sunday and today. She reports that she will call back. We notified mom of the error on Friday shortly after administration and no adverse event was reported but we did notify her that local irritation and burning may occur per Pfizer.
Cough Chest congestion; Phlegm in throat; Fatigue; Encouraged to continue with the Mucinex; Encouraged Tylenol for aches pains and fevers; Encourage plenty of fluids.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 22Dec2020 at 08:00 as dose 1, single (Lot number: EK4175), in left arm, on 12Jan2021 at 08:00 as dose 2, single (Lot number: EK4238), in left arm, on 30Aug2021 at 09:00 as dose 3 (booster), single (Lot number: FF8199), in left arm and on 25Jan2022 at 09:00 as dose 4 (booster), single (Lot number: FL3198) at the age of 71 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient was on treatment start date: 02Sep2022, treatment stop date: 06Sep2022 and paxlovid rebound, light cough, one bout of diarrhea, some fatigue on 13Sep2022; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Vaccine received post its 30 days Expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine received post its 30 days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022 at 3:05 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Feb-2022 at 3:05 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine received post its 30 days Expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine received post its 30 days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Vaccine administration time was given as 03-Feb-2022 at 15:05:02.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869 (Patient Link).
No adverse event; an expired dose of ROTATEQ was administered to a patient.; This spontaneous report was received from a medical assistant referring to a 4-month-old female patient. The patient had no known drug allergies (NKDA). The patient had history included hypoglycemia newborn, large for gestational age and single birth delivered by caesarean. Concomitant vaccine included pneumococcal conjugate vaccine (PCV13) (lot: FC0416).  The patient's concurrent conditions were not reported.  The patient was evaluated for her 4 month wellness. On 26-JUL-2022, the patient was vaccinated with second dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 milliliter/once, lot #1742079 with expiration date: 08-JUL-2022, administered orally for prophylaxis (strength was not provided); and second dose of diphtheria vaccine toxoid (+) hib vaccine conj (tet tox) (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (mrc 5) (+) tetanus vaccine toxoid (PENTACEL), lot: UJ50AA expiration date: 29-MAY-2022, intramuscularly (IM) on left thigh, administered for prophylaxis (strength, formulation, were not provided) (expired product administered). The patient's parent identified the event.   The rotavirus vaccine, live, oral, pentavalent (ROTATEQ) had no history of temperature excursions. Dose was supported by the post-expiry memo. The vaccine was available for return or evaluation. It was reported as single use vaccine. The operator of vaccine/was healthcare professional. The operator was trained. The vaccine had been disposed. The event had reported to doctor, health department and manufacturer. The vaccine was vaccinated at private doctor's office/hospital. The vaccine was purchased with private funds. There was no temperature excursion.   The patient did not have any adverse effects or symptoms following administration (no adverse event).
This spontaneous report was received from a Registered Nurse concerning a 16 month old patient (gender not reported) who on 05-NOV-2015 (also reported as "today"), was vaccinated with an expired dose of (Oka/Merck VARIVAX (lot no. J012210, exp. 28-SEP-2015) (route and site not reported). No adverse event was reported. Additional information has been requested.
Patient reports pain in left jaw (TMJ) 1 day after receiving Moderna Bivalent vaccine. Tenderness in left TMJ with movement, when opening mouth, and when chewing. Did report some swelling to TMJ on the left as well.
Narrative:  Received COVID Booster at 1:30 PM, and angioedema of the upper  lip began at 2:00 PM. Received above medications to counteract reaction. Also  sent home w/ prednisone taper. D/c'ed at 1730 with full resolution of symptoms.
Recently I had a bad cold that developed into pneumonia. 03/16/2023, It was like a head cold with congestion. It developed into a hacking cough with wheezing. I contacted my doctor. He suggested a lung x-ray. They found it was pneumonia in the bottom of one lung. I was prescribed several medication benzonatate, prednisone and doxycycline. I feel good now, just a touch of a cold and congestion not much. In October I contracted COVID-19 from a cruise and came back with it. I felt pretty sick thinking it was a cold. It was congestion and coughing. I was taking VICK'S NYQUIL at night. We did get tested at a pharmacy. We stayed home and took it easy. I think my symptoms lasted for about 5 days.
mom states 2 days p/vax pt had mild red rash, soreness & knots @ sites of inj;10/2 pt hosp x 2 days p/seen in ER;had sz in hosp;T101-102;very irritable & crying;mom states child is not walking well-MD has ordered motrin/PAP;